Association between loop diuretic use and fracture risk

Osteoporosis International

Volumn 26, Issue 2, 2015, Pages 775-784

  Xiao, F ^a   Qu, X ^a   Zhai, Z ^a   Jiang, C ^a   Li, H ^a   Liu, X ^a   Ouyang, Z ^a,b   Gu, D ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b The First People s Hospital of Changde City)   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Case control study; Fracture; Loop diuretic; Meta analysis; Prospective cohort study

Indexed keywords

LOOP DIURETIC AGENT;

ARM FRACTURE; ARTICLE; BONE DENSITY; DISEASE ASSOCIATION; DRUG USE; FOLLOW UP; FRACTURE; HIP FRACTURE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; WRIST FRACTURE; CHEMICALLY INDUCED; FRAGILITY FRACTURE; META ANALYSIS; METHODOLOGY; PROCEDURES; RISK ASSESSMENT;

HIP FRACTURES; HUMANS; OSTEOPOROTIC FRACTURES; RESEARCH DESIGN; RISK ASSESSMENT; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84925461411     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2979-8     Document Type: Article

References (47)

1. Michaelsson K, Nordstrom P, Nordstrom A, Garmo H, Byberg L, Pedersen NL, Melhus H (2014) Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins. J Bone Miner Res 29:424–431
2. Koh GC, Tai BC, Ang LW, Heng D, Yuan JM, Koh WP (2013) All-cause and cause-specific mortality after hip fracture among Chinese women and men: the Singapore Chinese Health Study. Osteoporos Int 24:1981–1989
3. Gronskag AB, Romundstad P, Forsmo S, Langhammer A, Schei B (2012) Excess mortality after hip fracture among elderly women in Norway. The HUNT study. Osteoporos Int 23:1807–1811
4. Sheng J, Qu X, Zhang X et al (2014) Coffee, tea, and the risk of hip fracture: a meta-analysis. Osteoporos Int 25:141–150
5. Qu X, Huang X, Jin F, Wang H, Hao Y, Tang T, Dai K (2013) Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 166:385–393
6. Qu X, Zhang X, Qin A, Liu G, Zhai Z, Hao Y, Li H, Zhu Z, Dai K (2013) Bone mineral density and risk of breast cancer in postmenopausal women. Breast Cancer Res Treat 138:261–271
7. Qu X, Zhang X, Zhai Z, Li H, Liu X, Li H, Liu G, Zhu Z, Hao Y, Dai K (2014) Association between physical activity and risk of fracture. J Bone Miner Res 29:202–211
8. Drake MT, Murad MH, Mauck KF et al (2012) Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 97:1861–1870
9. Kanis JA, Johnell O, Oden A et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162
10. De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338
11. Shen C, Chen F, Zhang Y, Guo Y, Ding M (2014) Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis. Bone 64:246–253
12. Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE (2008) Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 168:735–740
13. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D (2008) Resistant hypertension: diagnosis, evaluation, and treatment a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51:1403–1419
14. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337–344
15. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2005) Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med 257:176–184
16. Rose BD (1991) Diuretics. Kidney Int 39:336–352
17. Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L (2006) Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide. J Bone Miner Res 21(1):163–170
18. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47:40–50
19. Arampatzis S, Gaetcke LM, Funk GC, Schwarz C, Mohaupt M, Zimmermann H, Exadaktylos AK, Lindner G (2013) Diuretic-induced hyponatremia and osteoporotic fractures in patients admitted to the emergency department. Maturitas 75:81–86
20. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y (2013) Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 24:689–695
21. Rashiq S, Logan RF (1986) Role of drugs in fractures of the femoral neck. BMJ 292:861–863
22. Cumming RG, Klineberg RJ (1993) Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 158:414–417
23. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012
24. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65–W94
25. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3:e123–e130
26. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
27. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157:940–943
28. Zhang J, Yu KF (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690–1691
29. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
30. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
31. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
32. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
33. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2007) Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med 26:4544–4562
34. Tromp A, Ooms M, Popp-Snijders C, Roos J, Lips P (2000) Predictors of fractures in elderly women. Osteoporos Int 11:134–140
35. Carbone LD, Johnson KC, Bush AJ, Robbins J, Larson JC, Thomas A, LaCroix AZ (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169:132–140
36. Lim LS, Fink HA, Blackwell T, Taylor BC, Ensrud KE (2009) Loop diuretic use and rates of hip bone loss and risk of falls and fractures in older women. J Am Geriatr Soc 57:855–862
37. Solomon DH, Mogun H, Garneau K, Fischer MA (2011) Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 26:1561–1567
38. Heidrich FE, Stergachis A, Gross KM (1991) Diuretic drug use and the risk for hip fracture. Ann Intern Med 115:1–6
39. Jensen J, Nielsen LH, Lyhne N, Hallas J, Brosen K, Gram LF (1991) Drugs and femoral neck fracture: a case–control study. J Intern Med 229:29–33
40. Partanen J, Heikkinen J, Jamsa T, Jalovaara P (2002) Characteristics of lifetime factors, bone metabolism, and bone mineral density in patients with hip fracture. J Bone Miner Metab 20:367–375
41. Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117–124
42. Bilik D, McEwen LN, Brown MB et al (2010) Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab 95:4560–4565
43. Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L (2003) Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 33:41–50
44. Power ML, Heaney RP, Kalkwarf HJ, Pitkin RM, Repke JT, Tsang RC, Schulkin J (1999) The role of calcium in health and disease. Am J Obstet Gynecol 181:1560–1569
45. Poon IO, Braun U (2005) High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 30:173–178
46. Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ (2007) Will my patient fall? JAMA 297:77–86
47. Berry SD, Mittleman MA, Zhang Y, Solomon DH, Lipsitz LA, Mostofsky E, Goldense D, Kiel DP (2012) New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf 21:560–563